Last Updated: 08/09/2025

Optimizing a nanopore-based assay for malaria resistance markers (NOMADS)

Objectives

This project aims at:

  1. Production of an optimized malaria drug resistance assay using nanopore sequencing;
  2. Build local sequencing capacity;
  3. Deploy sequencing for national molecular malaria surveillance; and 
  4. Utilizing whole genome sequencing to enhance and augment our understanding of COVD-19 transmission in Zambia. 
Principal Institution

PATH, United States

Principal Investigators / Focal Persons

Mulenga Mwenda-Chimfwembe
Daniel Bridges
Jason A. Hendry

Partner Investigators

Busiku Hamainza

Date

May 2020 — Feb 2022

Total Project Funding

$832,337

Funding Details
Project Site

Zambia

SHARE
SHARE